It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by Chiiru
Originally posted by Regenmacher
Looks like a big scamola, same crock as Air Force One making a panic scene.
Only 7 swine flu deaths, not 152, says WHO
"Unfortunately that [150-plus deaths] is incorrect information and it does happen, but that's not information that's come from the World Health Organisation," Ms Allan told ABC Radio today.
"That figure is not a figure that's come from the World Health Organisation and, I repeat, the death toll is seven and they are all from Mexico."
why would they shoot those numbers out, then downplay?
Medicago, a biotechnology company in Quebec, took advantage of the swine flu. More than 6 million shares of Medicago have changed hands at the Exchange since Monday morning. The action went from 20 cents to 30 cents. In addition to the subject of major speculation in the stock market, the company is attracting interest among investors, "says Frederic Ors, vice-president of development in Medicago. "There's a lot of potential investors and people wishing to get information about who is Medicago, how to respond to pandemic influenza, what can we do," says Ors. Two reasons for investor interest in Medicago. The company has successfully developed a new technology for rapid production, with plants, vaccines against influenza. Moreover, after having produced a vaccine against bird flu, the Quebec company began to manufacture a vaccine against swine influenza. Work has already begun, said Frederic Ors. "We recovered the gene sequence of the Center for Infectious Diseases in the United States. It was recovered on Monday and Friday morning, we began to work in the laboratory in order to produce as quickly as possible this vaccine, "he says. The technology can produce a vaccine barely a month after the identification of the gene sequence from a new pandemic strain. The vaccine will be given to Health Canada. If laboratory, the vaccine manufactured by Medicago proved effective, it would not be marketed immediately. It should be evaluated to determine if it complies with the requirements concerning the approval of vaccines.